U.S. Levodopa prices, which had a very minor increase in August 2025, are expected to modestly increase again in September, according to experts in the market. Levodopa is one of the most critical medicines used mostly in the treatment of Parkinson's disease, and it usually has steady demand regardless of the time of year. But recent supply chain mishaps, increasing freight rates, and upcoming Chinese export closures during the Golden Week holiday will continue to support a soft upward trend. The inflationary impetus in the U.S. is also adding to the cost base, leading purchasers to purchase guardedly anticipating eventual delays.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
